Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy
Saved in:
Corporate Authors: | , , , |
---|---|
Format: | Electronic eBook |
Language: | English |
Published: |
Lyon, France : Geneva :
International Agency for Research on Cancer ; Distributed by WHO Press,
2007.
|
Series: | IARC monographs on the evaluation of carcinogenic risks to humans ;
v. 91. |
Subjects: | |
Online Access: | An electronic book accessible through the World Wide Web; click to view |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000Ia 4500 | ||
---|---|---|---|
001 | 0000103137 | ||
005 | 20171002055348.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 080729s2007 fr a sb i001 0 eng d | ||
020 | |z 9789283212911 | ||
020 | |z 9283212916 | ||
035 | |a (CaPaEBR)ebr10255175 | ||
035 | |a (OCoLC)549589240 | ||
040 | |a CaPaEBR |c CaPaEBR | ||
050 | 1 | 4 | |a RC268.7.O72 |b I19 2007eb |
110 | 2 | |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans |d (2005 : |c Lyon, France) | |
245 | 1 | 0 | |a Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |h [electronic resource]. |
260 | |a Lyon, France : |b International Agency for Research on Cancer ; |a Geneva : |b Distributed by WHO Press, |c 2007. | ||
300 | |a ix, 528 p. : |b ill. | ||
490 | 1 | |a IARC monographs on the evaluation of carcinogenic risks to humans ; |v v. 91 | |
500 | |a At head of title: World Health Organization, International Agency for Research on Cancer. | ||
500 | |a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005." | ||
504 | |a Includes bibliographical references and cumulative index. | ||
533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2011. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
650 | 0 | |a Progestational hormones |x Carcinogenicity. | |
650 | 0 | |a Progestational hormones |x Side effects. | |
650 | 0 | |a Catechol estrogens |x Carcinogenicity. | |
650 | 0 | |a Estrogen |x Carcinogenicity. | |
650 | 0 | |a Catechol estrogens |x Side effects. | |
650 | 0 | |a Estrogen |x Side effects. | |
650 | 0 | |a Contraception |x Complications. | |
650 | 0 | |a Menopause |x Hormone therapy |x Complications. | |
650 | 0 | |a Chemical carcinogenesis. | |
650 | 0 | |a Cancer |x Risk factors. | |
650 | 0 | |a Women |x Diseases |x Risk factors. | |
650 | 0 | |a Oral contraceptives |x Carcinogenicity. | |
655 | 7 | |a Electronic books. |2 local | |
710 | 2 | |a World Health Organization. | |
710 | 2 | |a International Agency for Research on Cancer. | |
710 | 2 | |a ebrary, Inc. | |
830 | 0 | |a IARC monographs on the evaluation of carcinogenic risks to humans ; |v v. 91. | |
856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10255175 |z An electronic book accessible through the World Wide Web; click to view |
908 | |a 170314 | ||
942 | 0 | 0 | |c EB |
999 | |c 92289 |d 92289 |